Minor
ALISCA-Lung2 · Alisertib and Paclitaxel · Small Cell Lung Cancer (SCLC)
Start date changed from estimate of Sep 30, 2026 to Sep 17, 2026
Puma Biotechnology, Inc.Phase 2 NCT07465757 Registry history of NCT07465757 on ClinicalTrials.gov (opens the registry)